Brain Tumor Investment Fund (investor - Others)

United States
See something wrong or missing? Let us know
Offices:Boston
Average round investment:56.41M USD
Average number per year:1.0
Distribution: 2025 (1)2023 (1)
Portfolio companies: United Kingdom Trogenix
Mostly invests in: United Kingdom United Kingdom (2) Biotech (2)

2 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Brain Tumor Investment Fund

Name Criteria
United States Allen & Company
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Hercules Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Venture Science
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Fearless Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Integrated
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Adage Capital Management
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Negev Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Abingworth
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States National Resilience
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Walden Catalyst Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top